Copyright 2024 All rights reserved.

Pipelines

Stem Medicare is developing EV-based new drugs for various diseases

as well as regenerative medicines based on the world's only non-immunogenic,

immune-tolerized extracellular vesicle technology.

Pipelines

Neurodegenerative Diseases

Immune-tolerized extracellular vesicles therapeutics for neurodegenerative disorders (MBTC-ND-EVs)

Mode of Action
(MOA)
MBTC-ND-EVs
  • Immune-tolerized extracellular vesicle therapeutics for treatment of neurodegenerative and congenital neurological disorders including Alzheimer’s, Parkinson’s diseases, and Austin disorder
  • MOA : Anti-inflammation, Degradation of reactive proteins including amyloid-β, neuroprotection & neurogenesis, Enhanced angiogenesis, normalization of autophagy & mitochondria functions
  • Unlike stem cells, MBTC-ND-EVs can pass through the Blood-Brain-Barrier (BBB) and reach the brain and nervous system.